FIELD: medicine.
SUBSTANCE: invention relates to using a gadolinium complex of [1-(4-perfluorooctylsulfonyl)piperazine]amide of 6-N-[1,4,7-tris-(carboxylatomethyl)-1,4,7,10-tetraazacyclododecane-10-N-(pentanoyl-3-aza-4-oxo-5-methyl-5-yl)]-2-N-[1-O-α-D-carbonylmethylmannopyranose]-L-lysine as a contrasting substance used in method of the magnetic-resonance tomography in visualization of patches.
EFFECT: enhanced precision of diagnosis.
3 tbl, 136 ex
Title | Year | Author | Number |
---|---|---|---|
PERFLUOROALKYL-CONTAINING COMPLEXES WITH SUGAR RESIDUES, METHODS FOR THEIR PREPARING | 2001 |
|
RU2280644C2 |
PERFLUOROALKYL-CONTAINING COMPLEXES WITH POLAR RESIDUES, METHOD FOR THEIR PREPARING, PHARMACEUTICAL AGENT | 2001 |
|
RU2289579C2 |
PERFLUOROALKYL-CONTAINING COMPOUNDS, METHOD FOR THEIR PREPARING (VARIANTS) AND PHARMACEUTICAL AGENT CONTAINING INDICATED COMPOUNDS | 1997 |
|
RU2242477C2 |
METAL CHELATES HAVING PERFLUORINATED PEG RADICAL, METHODS FOR PRODUCTION THEREOF AND USE THEREOF | 2007 |
|
RU2470014C2 |
COMPOUND AND METHOD OF PREPARATION THEREOF | 2002 |
|
RU2305096C2 |
APPLICATION OF PERFLUORALKYL-CONTAINIG METAL COMPLEX AS CONTRAST MEDIUM TO VISUALISE INTRAVASCULAR THROMBI DURING MAGNETIC RESONANCE IMAGING | 2003 |
|
RU2328310C2 |
NEW GADOLINIUM CHELATE COMPOUNDS WITH HIGH RELAXIVITY FOR USE IN MAGNETIC RESONANCE IMAGING | 2017 |
|
RU2755181C2 |
CASCADE POLYMER COMPLEXES, DIAGNOSTIC CONTRAST SUBSTANCE CONTAINING THEREOF, AND INTERMEDIATES | 1996 |
|
RU2197495C2 |
CASCADE POLYMERIC COMPLEXES, PARENT COMPOUNDS AND PHARMACEUTICAL COMPOSITION | 1996 |
|
RU2166501C2 |
CONJUGATES PRODUCED FROM METAL AND OLIGONUCLEOTIDE COMPLEXES, MEANS CONTAINING THE CONJUGATES, METHOD FOR PRODUCING AND USING THE CONJUGATES IN RADIOLOGICAL DIAGNOSIS | 1995 |
|
RU2165771C2 |
Authors
Dates
2006-12-27—Published
2001-07-23—Filed